ESC 365 - Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors

ESC Professional Premium Access

Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors

Session: Pharma Made Easy

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor S. Massberg (Munich, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Steffen Massberg

Ludwig Maximilians University, Munich (Germany)

7 presentations

0 follower

5 more presentations in this session

Lipid lowering agents: how to make optimal use of the full spectrum

Speaker: Professor F. Mach (Geneva, CH)

Lipid lowering agents: how to make optimal use of the full spectrum - discussion

GLP-1 agonists: how do they work?

Speaker: Professor U. Laufs (Leipzig, DE)

GLP-1 agonists: how do they work? - discussion

Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors - discussion

Access the full session

Pharma Made Easy

Speakers: Professor S. Massberg, Professor F. Mach, Professor U. Laufs

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources